1. Home
  2. TOVX vs AEMD Comparison

TOVX vs AEMD Comparison

Compare TOVX & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOVX
  • AEMD
  • Stock Information
  • Founded
  • TOVX 2001
  • AEMD 1984
  • Country
  • TOVX United States
  • AEMD United States
  • Employees
  • TOVX N/A
  • AEMD N/A
  • Industry
  • TOVX Biotechnology: Pharmaceutical Preparations
  • AEMD Medical/Dental Instruments
  • Sector
  • TOVX Health Care
  • AEMD Health Care
  • Exchange
  • TOVX Nasdaq
  • AEMD Nasdaq
  • Market Cap
  • TOVX 3.8M
  • AEMD 4.1M
  • IPO Year
  • TOVX 2006
  • AEMD N/A
  • Fundamental
  • Price
  • TOVX $0.43
  • AEMD $1.22
  • Analyst Decision
  • TOVX Hold
  • AEMD Strong Buy
  • Analyst Count
  • TOVX 1
  • AEMD 1
  • Target Price
  • TOVX N/A
  • AEMD $56.00
  • AVG Volume (30 Days)
  • TOVX 1.6M
  • AEMD 265.2K
  • Earning Date
  • TOVX 08-12-2025
  • AEMD 06-26-2025
  • Dividend Yield
  • TOVX N/A
  • AEMD N/A
  • EPS Growth
  • TOVX N/A
  • AEMD N/A
  • EPS
  • TOVX N/A
  • AEMD N/A
  • Revenue
  • TOVX N/A
  • AEMD N/A
  • Revenue This Year
  • TOVX N/A
  • AEMD N/A
  • Revenue Next Year
  • TOVX N/A
  • AEMD N/A
  • P/E Ratio
  • TOVX N/A
  • AEMD N/A
  • Revenue Growth
  • TOVX N/A
  • AEMD N/A
  • 52 Week Low
  • TOVX $0.40
  • AEMD $1.20
  • 52 Week High
  • TOVX $7.37
  • AEMD $8.44
  • Technical
  • Relative Strength Index (RSI)
  • TOVX 33.63
  • AEMD 41.34
  • Support Level
  • TOVX $0.43
  • AEMD $1.40
  • Resistance Level
  • TOVX $0.46
  • AEMD $2.88
  • Average True Range (ATR)
  • TOVX 0.04
  • AEMD 0.26
  • MACD
  • TOVX 0.02
  • AEMD -0.02
  • Stochastic Oscillator
  • TOVX 15.54
  • AEMD 36.49

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Share on Social Networks: